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It is now well established that viruses of the murine leukemia virus (MuLV)' 
group are present ifi all mi~ (1, 2) and that viral genetic sequences are present 
as chromosomal DNA (3-5).  The expression of this genetic material, as virus 
particles or viral antigens, differs markedly between strains of mice, both with 
regard to the age at which the expression occurs  (6-8)  and the  spectrum of 
biologic indicators of this expression (7-10).  The genetic basis of these differ- 
ences in expression pattern has been the subject of much interest, and has been 
studied in a variety of genetic crosses, using a variety of biologic indicators (11- 
15). While much information on the genetic patterns has been obtained, all such 
studies have suffered from one (or both) of two drawbacks: Either the animals 
have been scored for only one or two of the many parameters of  virus expression, 
or  the  genotype  has  been  inferred  from  the  phenotypic ratios  in  a  single 
segregating generation rather than being confirmed by progeny testing. 
A particularly helpful stop in understanding the complex patterns of MuLV expression 
was the recognition that there are several classes of MuLV, differing markedly in their 
ability to spread  from one  cell to another.  Mouse-tropic strains,  represented by the 
classical Gross-AKR viruses, can infect mouse cells; these viruses are of two host range 
types, N tropic and B tropic (16) and the efficiency with which they infect mouse cells 
depends on the Fv-1 genotype of the cells (see review 17). The hereditary transmission of 
Gross-AKR-type virus in AKR mice (Fv-ln) is determined by two dominant unlinked loci, 
Akv-1  (chromosome 7) and Akv-2 (chromosome ?) (7), and the Fv-1 b allele has a marked 
suppressive  influence  (genetically dominant) on the expression  of these viruses in the 
progeny of crosses between AKR and Fv-lb mouse strains (8). Other MuLV strains are 
xenotropic (9, 10, 18), being almost completely unable to establish exogenous infection of 
mouse cells, regardless of the Fv-1 type. 
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In mice carrying mouse-tropic virus,, wehave a  working model according to which 
induction of genetically transmitted virus occurs in some cells,  the virus disseminates to 
infect other cells, and a broad array of viral antigens are expressed as part of the viral 
replicative process (19). Involvement of sufficient numbers of cells to register a positive 
result in an assay for virus or viral antigens depends both on the frequency of sponta- 
neous induction and on the Fv-1 type in relation to the virus-host range type. 
Antigen expression in the absence of infectious Gross-AKR-type MuLV Cnoninfectious 
antigen expression") is different in several important respects. Since cell-to-cell  spread of 
infection is presumably not a factor, a detectable level of antigen expression depends only 
on the number of cells undergoing spontaneous induction, and is not affected by Fv-1 
type.  Antigen synthesis resulting from spontaneous induction of viral  gene functions 
could be associated with synthesis of C-type particles representing xenotropic MuLV, 
defective mouse-tropic MuLV, or other unknown viruses of the MuLV group, or could 
occur in the absence of virus particle synthesis if only a  portion of the viral genome is 
transcribed.  The NZB mouse exemplifies the former (9,  18), while the  129 mouse may 
exemplify the latter mechanism (11, 20, 21). 
Inheritance of p30,  the major internal  protein of MuLV (identified by group-specific 
antigenic reactivity), has been studied in systems where Gross-AKR-type virus is repre- 
sented, and also in systems where it is not represented. In virus-positive systems (crosses 
involving AKR) the presence (12) and amount (14) of p30 was highly concordant with the 
presence of virus.  In virus-negative systems (denoting those in which Gross-AKR-type 
virus  was  either  not  present  or  not  expressed)  p30  expression  has  been  reported  as 
recessive in one study [mouse strain B10.D2(58N); reference 13] but dominant in another 
(mouse strain NIH Swiss)  (H. Ikeda and W. P. Rowe, unpublished observation). 
Study of genetic control over expression of the MuLV-associated antigen G~x 
has been carried out mainly in a virus-negative system, mouse strain 129 (11, 22) 
in  which  (as  in  other  G~x  ÷  virus-negative  mouse  strains)  the  Gxx  antigen  is 
expressed  predominantly on thymocytes. In crosses involving this  strain,  G~x 
expression  is  determined  by  two  genes,  one  semidominant  (Gv-1)  and  one 
dominant  (Gv-2).  Both  Gv-1  and  Gv-2  are  required  for  expression,  and  the 
genotype is fully penetrant. 
The main purpose of the study which follows was to examine the qualitative 
and  quantitative  interrelationships  of G]x,  p30,  and  MuLV expression  in  the 
virus-positive, antigen-positive system represented by segregants derived from 
AKR and C57L (a virus-negative, Fv-l-compatible strain) progenitor mice. 
Materials  and  Methods 
Mice. The  parental  strains,  AKR  (AK) and  C57L (CL) were  obtained  from  The "Jackson 
Laboratory, Bar Harbor,  Maine, or from our colonies, which were originally  established  from 
Jackson breeders. The naming of crosses in the text follows the convention that the strain of the 
mother is given first. Virologic and other relevant data for these two strains and for the FI hybrid 
are summarized in Table I. 
Backcross segregants  were tested for MuLV (XC test on tail biopsy at 5-6 wk of age); for Glx 
(cytotoxicity test on thymocytes sampled  at 5-7 wk of age); and for p30 (immunofluorescence 
absorption [IFA] test on spleens removed surgically at 8-10 wk of age). Most segregants were also 
tested for H-2 (cytotoxicity test on lymph node cells) and Gpd-1 (vertical starch gel electrophoresis 
on kidney). 
Antisera 
"ANTI-NTD."  Anti-NTD is a common abbreviation  for the antiserum  (W/Fu ×  BN)F1 anti- 
W/Fu(C58NT)D originally described by Geering et al. (30). W/Fu and BN are inbred rat strains, 34  MURINE  LEUKEMIA  VIRUS  ANTIGENS  IN  AKR  CROSSES 
TABLE I 
MuLV Expression and Other Relevant Data for AK,  CL, and  (CL  x  AK)F~ 
AK  CL  (CL x AK)F~  References 
Gross-AKR MuLV infectivity  + + + +  -  + + + +  7 
Xenotropic MuLV  +  +  23, 24 
p30 (spleen)  + +  -*  ++  25, See text 
G~x (thymus)  + +  -  +  11, See text 
MuLV sequences in cell DNA 
"Gross-AKR-unique sequences"  + 
"Common sequences"  + +  ++ 
4, 5 
Akv genotype  V~  -  7, 8 
V2 
G~x genotype  Gv-1 (?)  - 
Gv-2 (?)  Gv-2 
26, See text 
Fv-1  n  n  27, 28 
H-2  k  b 
Gpi-1  a  a 
Gpd-1  b  a 
* Although the phenotype of the CL parent is given here as V-p30-G~x-, viral antigen is detectable 
in CL mice by the sensitive radioimmunoaasay (25,  29)  and the amount of antigen may well 
increase with age (6). 
and leukemia W/Fu(C58NT)D  is  a W/Fu rat  leukemia induced by wild-type MuLV. This antiserum 
was used for G~x typing (see  below). 
RABBIT  ANTI-MULV p30.  The rabbit antiserum to p30 of  MuLV-Rauscher  (p30  fraction  rechro- 
matographed in guanidine hydrochloride gel filtration)  was kindly provided by Doctors E. Fleis- 
sner and W. D. Hardy, Jr.,  Memorial Sloan-Kettering Cancer Center, New York. 
In the indirect  immunofluorescence  (IF)  test,  this  antiserum gives bright diffuse  cytoplasmic 
fluorescence of  acetone-fixed MuLV-infected cells  (31)  (titer  approximately 1:1,000);  in confirma- 
tion  of  the  specificity  of  the antiserum, this  IF activity  was specifically  absorbed by p30 fraction  of 
MuLV-Rauscher  (32); the IF reaction was also blocked  by goat antiserum  to p30 of MuLV- 
Rauscher (serum kindly provided by Doctors M. Strand and J. T. August of Albert Einstein 
College of  Medicine, Bronx, N. Y.). 
Gix Typing of Thymocytes.  Cytotoxicity assay for Glx on thymocytes was done according to 
Stockert et al.  (11). Briefly, equal volumes (50 #l) of anti-NTD serum (serially diluted), comple- 
ment (selected rabbit serum 1:15), and cells (5  ×  l0  s thymocytes/ml) are mixed and incubated at 
37°C for 45 min; viability counts (percent cells lysed) are then made in the presence  oftrypan blue. 
Rat natural antibody to mouse thymocytes was removed from the anti-NTD serum by absorption 
with spleen cells and thymocytes of Gjx- mouse strains, always including CL. 
The anti-NTD serum was used at dilutions of 1:20 and 1:40;  with this amount of serum the 
proportion of thymocytes lysod in the cytotoxicity assays is 80-90% for AK mice [G~x(+ +)]; 40-50% 
for (CL x AK)F~ or G]x-positive heterozygous segregants [G[x(+)];  and less than 10% for CL or Gxx- 
negative backcross segregants  [G~x(-)].  The  intermediate reading for the  hybrid  (40-50%)  is 
attributable to the relative weakness of the cytotoxicity reaction with thymocytes showing only 
hemiexpression of antigen; it does not signify a mixture of G~x + and Gix- cells. 
Anti-NTD contains antibodies to several MuLV-associated antigens in addition to G[x (30). The 
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(a) that 129 thymocytes (G]x+/MuLV  -) remove all activity for young AK thymocytes (G~x+/MuLV+), 
and (b) that AK thymocytes remove all activity for 129 thymocytes. 
IFA Test for MuLV p30 antigen.  The method of Hilgers et al. (33) with modifications described 
elsewhere  (31)  was  used.  Briefly,  the standard  test cell was  leukemia  E~G2  (a transplanted 
C57BL/6 leukemia induced by passage A  Gross virus). E~G2 cells were incubated for 20 min at 
37°C on microscope slides and then fixed with acetone. These slides were stored at -70°C. 
In typing spleens for presence of p30,  a  20% wt/vol homogenate of spleen was  prepared in 
phosphate-buffered saline (PBS) and then senicated for 3-5 s with a  Biosonik IV, Will Scientific, 
Inc., Rochester, N. Y. After centrifugation at 2,000 g  for 30 rain at 4°C, the supernate ("antigen") 
was stored at -70°C. 
20/~l of antigen (serially diluted) was mixed with an equal volume of anti-p30 serum  (at a 
predetermined critical dilution in the region of 1:250),  incubated overnight at 4°C, and tested for 
residual IF activity. For this purpose, the antigen-antibody preparations were applied for 1 h  at 
37°C to the acetone-fixed E~G2 cells; the slides were then washed with PBS, and further reacted 
with fluorescein-conjugated goat antirabbit IgG (Hyland Div., Travenol Laboratories, Inc., Costa 
Mesa, Calif.) for 1 h  at 37°C.  After removal of excess conjugate, the slides were counterstained 
with 0.5% Evan's-Blue, and examined for intensity of IF staining. The antigen titer is expressed as 
the highest dilution giving substantial  reduction of IF activity; the base-line figures  are 8  or 
higher for AK or (CL x  AK)FI spleen [p30(+ +)]; 1-4 for NIH Swiss [p30(+)], and <1 for CL spleen 
[p30(-)]. 
The IFA test as described above is strictly a test for the presence of the group-specific antigen of 
p30, the major internal component of MuLV. 
Virus Testing.  At 6 wk of age, mice were tested for MuLV in tail tissue, using the XC plaque 
assay as described previously (34).  In the earlier stages of the study, virus assays were done in 
secondary cultures of NIH Swiss mouse embryo, while later assays, representing half of the first 
backcross (Bc-1) generation and all of the Bc-2 and Bc-3 mice, were done in the SC-1 clonal line of 
feral mouse embryo cells (35). The SC-1 cell line is about 10-fold more sensitive than NIH mouse 
embryo for detection of naturally occurring MuLV; however, the proportion of Bc-1 mice positive 
for virus was not significantly affected by the cell type used for testing (72% positive in NIH, and 
76% in SC-1 cells). 
Results 
Bc-1 generation.  A  total  of  180  [CL  ×  (CL  x  AK)]  backcross  mice  were 
studied,  representing successive  litters of 9 CL females mated with  10 (CL  x 
AK)F1  males. Table II shows the results of typing these 180 backcross mice for 
TABLE  II 
Typing of 180 (CL × [CL  × AK]) Backcross Mice for MuLV (V), 
p30, and G~x 
Phenotype  No.  of mice 
V (tail)*  p30* (spleen)  G]x (thymus) 
+  +  +  97 
+  +  -  34 
+  -  +  0 
+  -  -  3 
-  +  +  7 
-  +  -  10 
-  -  +  2 
-  -  -  27 
Total 180 
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MuLV  in  the  tail  (V +  vs.  V-),  p30  in  spleen  (p30  +  vs.  p30-),  and  G,x  on 
thymocytes (G1x  + vs. G,x-).  The data will first be considered as they stand, and 
the conclusions later amplified (below) in the light of progeny testing of individ- 
ual members of this backcross population. 
Overall, 74% (134/180) were positive for MuLV (V+), 82% (148/180) for p30, and 
59%  (106/180) for G1x. These data confirm the existence in AK of at least two 
unlinked loci determining appearance of infectious MuLV early in life ("V loci") 
(7), and they suggest that there are at least three discrete loci determining p30. 
Comment on the apparent G1x segregation figures recorded in Table II will be 
deferred until progeny testing (Tables III and V) has been considered, because 
progeny testing is especially relevant to interpretation in the case of G,x. 
The three markers show strong associations with each other both  qualita- 
tively and quantitatively (Fig. l). The phenotypes for p30 (spleen) ranged from 
high [+ + as in AK and the (CL x AK)F, hybrid], through intermediate (+ as in 
DBA/2  or NIH Swiss mice), to negative (-),  evidently reflecting MuLV titers 
more than gene dosage; i.e., higher titers of MuLV tended to be associated with 
higher titer of p30 (see Fig. 1). 
The incidence of the Gix  + phenotype was higher among segregants with high 
MuLV and p30  (+ +) levels (Fig. i). However, the quantitative level of expres- 
sion of G,x on thymocytes  of the segregants was always apparently equal to that 
of  the (CL x  AK)FI hybrid [G,x(+)], regardless of the MuLV and p30 titers. This 
was confirmed by the following test: Thymocytes of G~x  + backcross segregants 
were compared with thymocytes  of (CL x AK)F1 mice in quantitative absorption 
tests for G,x antigen (cytotoxicity assay with anti-NTD serum and 129 thymo- 
cytes; see reference ll). The absorption capacity of both thymocyte populations 
was the same, and equalled half the absorption capacity of AK thymocytes, the 
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FIG.  1.  Concordance  for the three MuLV markers (V, p30, and G,x) among the 180 Bc-1 
segregants. Closed circle: Family CL£ number 40 (see Table VII). MuLV titer (log 10): 
+ + + +, ->3 in SC-1 or ->2 in NIH-ME; + + +, 2-2.9 in SC-1 or 1-1.9 in NIH-ME; + +, 1-1.9 in 
SC-1 or 0-0.9 in NIH-ME; +, 0-0.9 in SC-1; and -, negative in SC-1 or NIH-ME. IKEDA,  ROWE,  BOYSE,  STOCKERT,  SATO,  AND  JACOBS  37 
parental  homozygous  strain.  Thus,  expression  of G~x  on  thymocytes,  unlike 
expression of p30 in spleen, was not quantitatively related to the MuLV titer of 
individual segregants. 
All but 3 of the 135 V + mice were p30  + (Table II); one of these three (V+p30  -) 
discrepant mice yielded V+p30  + segregants on progeny testing (c~  160 in Table 
III) suggesting that in fact these discrepant mice had given false negative scores 
for p30.  17 mice were V-p30+; essentially all of these showed the intermediate 
p30 phenotype [p30(+)].  Among V-  mice, the expression of G~x was generally 
associated with expression of p30; only 2 of 32 p30- segregants were G~x  ÷ (Table 
II). 
Progeny Testing.  The positive correlations among V, p30, and G~x in the Bc- 
1 generation could be interpreted as genetic linkage, interdependent manifesta- 
tions of MuLV activation  and  spread,  or both.  Also,  some of the  discordance 
between the three markers could be due to reduced penetrance or test errors. To 
assess these factors it was necessary to carry out progeny tests. For this purpose 
TABLE III 
Progeny testing of CL  x  (CL  x  AK) backcross mice mated to CL (representing a selected Bc-2 
population) 
Bc-1  % Bc-1  No. of progeny with given phenotype  Total %  Inferred 
mice  genotype 
phenotype  with  Bc- 1  V+  V-  positive  of parent 
rllouse 
--  phenotype  number 
V p30*  (See  p30/Gix  p30/Gix  V  p30  Gix  Ahv  Akvp$ 
Table If)  +/+  +/-  -/+  -/-  +/+  +/-  -/+  -/- 
+  +  54  ?  34  6  2  1  2  82  73  55  +  (2)§ 
?  108  4  1  2  57  71  57  +  +? 
+  -  19  c~  39  12  9  1  4  81  85  46  +  (2)  +ll 
42  6  9  1  7  65  70  26  +  +? 
~;  113  6  7  5  72  72  33  +  (2) 
153  12  3  3  83  83  67  +  (2) 
158  13  1  2  88  88  81  +  (2) 
159  5  2  2  56  78  78  +  (1)  +? 
35  1  6  6  54  54  8  +  (1) 
c~  132  2  4  33  33  0  + 
151  2  1  7  30  30  20  +  (1) 
-  2  ~  160 
201 
+  4  c~  95 
99 
c~  101 
-  6  ~  127 
137 
+  1  ~  135 
154 
-  15  ~  128 
138 
139 
200 
7  9 
1  5 
2  12  53  60  23  +  (1)  +? 
10  9  0  0  +  (1) 
7  4  11  0  50  32  +[[ 
11  16  3  9  0  69  35  +ll 
2  1  1  0  75  50  + 
3  14  0  18  0  + 
7  0  0  0 
3  4  20  0  26  11  + II 
2  33  33  33  + 
1  4  0  20  0 
22  0  0  0 
3  0  0  0 
7  46  46  8  +  (1) 
* Including p30(+) and  p30(+ +) phenotypes. 
* AKR locus giving V-p30  + phenotype (See text). 
§ Number in parenthesis  is the  estimated number of V genes. 
II Confirmed by progeny  testing  (See Table V). 38  MURINE  LEUKEMIA  VIRUS  ANTIGENS  IN  AKR  CROSSES 
a number of Bc-1 mice, selected to represent each observed Bc-1 phenotype, were 
bred with  CL,  and their  progeny (Bc-2 population)  were scored for the  same 
three  markers.  Similarly,  representative  mice  of this  Bc-2  generation  were 
mated with CL to provide a Bc-3 population. Tables III and V present the total 
Bc-2 and Bc-3 results in relation to the parental phenotypes, with our interpreta- 
tion of the genotypes of the parents (final columns of Tables III and V). It is seen 
that there are two classes of genes responsible for the virus-specific phenotypic 
markers;  the two previously established V genes, which give rise to infectious 
mouse-tropic MuLV, and a gene or genes which induce p30 and/or G,x antigen in 
the absence of such virus. 
EXPRESSION  OF p30 AND  G~x ANTIGENS  IN FAMILIES OF Bc PARENTS  CARRYING  V 
GENES (V+).  Here we are concerned with the progeny of V + Bc segregants. In 
these V + families, relationships among MuLV,  p30, and G~x phenotypes were 
essentially  the same as in the V + mice of  the Bc-1 population (Table IV).  That is, 
essentially all V + offspring were p30  + and the majority of these were p30(+ +) 
and  the  G1x  +  phenotype  was  found  primarily  in  V+p30(++)  mice.  Since 
V+p30(+)  parents generated p30(++) progeny in the next generation (Table 
IV), we conclude that the quantitative expression of p30 in segregants with V 
genes is mostly related to the titer  of MuLV  rather than to gene dosage. 
The incidence of the G~x  + phenotype in the V + segregants was about 55% in 
both the Bc-2 and Bc-3 generations,  and was the same in offspring of mice 
carrying one V gene as in mice carrying both V genes (Tables III  and V). While 
this ratio might suggest that an independently segregating epistatic gene is 
required in addition to a V gene for G~x expression, the following observations 
refute this interpretation: (a) The G~x  + phenotype was no more common  in the 
V + offspring  of  V+GIx  + parents than of  V+GIx  - parents. That is, among V + mice, 
TABLE  IV 
p30 and GIx Phenotypes of "V  ÷  Families" (Progeny of V+Bc Segregants Mated to CL) 
V + parent  Progeny (Bc-2 and Bc-3) 
Phenotypes of  segregants, % 
Generation  p30  No.  tested  Virus  No.  of  p30 
segregants 
++  + 
G,x ÷ 
Bc-1  + +  5  +  62  85  13  2  55 
-  23  0  13  87  0 
+  6  +  46  80  20  0  76 
-  26  0  8  92  0 
2  +  17  65  29  16  41 
-  24  0  8  92  0 
Bc-2  + +  6  +  26  73  27  0  42 
-  31  0  26  74  0 IKEDA,  ROWE,  BOYSE,  STOCKERT,  SATO,  AND  JACOBS  39 
TABLE V 
Progeny Testing of Selected Bc-2 Mice 
c-2 phenotype 
V  p30*  G[x 
Bc-2 
mouse 
number 
Bc-l$ 
parent 
number 
No. of progeny with given phenotype  Inferred 
Total %  genotype of 
V +  V-§  positive  Bc-2 parent 
p30/G,x  p30/G~x  V  p30  Gix  Akv  Akup" 
+/+  +/-  -/+  -/-  +/+  +/-  -/+  -/- 
~-  +  + 
+  - 
9  281 
Q  47 
?  87 
269 
91 
60 
59 
154 
113 
c~ 113 
C~  151 
113 
?  35 
?  35 
2  2  )  +  ? 
4  I  ?  ?  2  1  4  46  64  17  +(1)  ? 
7  8  11  +(1) 
+(1)  ? 
1  1  1  6 ~  40  45  20  +(1) 
3  2  5 }  + 
1 
+  ÷ 
+  - 
157 
69 
74 
76 
~'  95 
?  99 
99 
Q  99 
119  ~  39 
?  153  d  95 
40  Q  99 
d  77  Q  99 
157  ~  127 
?  141  Q 135 
? 174  $  128 
41  ?  99 
39  Q  99 
4,  'f  2  2 
4  4  4 
1  1  8 
62  !1 
5  2 
3  1 
10 
1 
2  5 
3 
0  50  21 
0  43  23 
0  0  4 
Including p30(+ +) and p30(+) phenotypes. 
For phenotype and progeny testing see Table IH. 
Mice with two generations of V- ancestry were assumed to be V-. 
AKR  locus giving V- p30  + phenotype (see text). 
the G~x phenotype of progeny was not predictable from the G~x phenotype of the 
Bc parent.  (b) The Gxx  + phenotype occurred mostly in p30(+ +) mice, and these 
tended  also  to be  the segregants  with  the higher  titers  of MuLV  (Fig.  1 and 
Table IV), indicating a stochastic element in the occurrence of the G~x  ÷ pheno- 
type.  Thus,  unless  we postulate  some  unrecognized  complex  mode of genetic 
determination for G~x, the G~x- phenotype seen in about half the V + segregants 
does not reflect the genotype. 
EXPRESSION  OF p30 AND  GIx ANTIGENS  IN  FAMILIES  OF Bc MICE  WITH  ~NONINFEC- 
TIOUS" p30/C~x GENES (Ec PARENTAL  PHENOTYPE  v-p30+).  As described  above, 
analysis of the Bc-1 generation revealed a  class of segregants that express p30 
alone,  or p30 and  G~x, but did  not produce detectable  virus.  Progeny  testing 
(Tables III and V) confirmed that there is indeed a genotype which expresses p30 
and G~x in the absence of detectable mouse-tropic MuLV. 
In addition to the usual tests for MuLV in tail extracts,  shown in Tables III 
and V, virus isolation tests were carried out on spleen extracts from each of 12 
progeny of Q 99 (V-p30+G~x+;  Table III) with consistently negative results even 
though 8  of these  12  mice  were  p30  ÷.  Also,  pooled embryos from matings  of 
V-p30+Gix + progeny of  ~  99 with  NIH  Swiss mice  did not yield  MuLV when 
grown in tissue culture and tested for 5-iodod.eoxy-uridine inducibility  of AK- 
type virus (1). Further analysis of this phenotype (V-p30+G~x  +) was hindered by 40  MURINE  LEUKEMIA  VIRUS  ANTIGENS  IN  AKR  CROSSES 
low fertility of the relevant mice after the Be-3 generation. 
All such V-p30  + mice in the Bc-2 and Bc-3 generations of these families were 
of the p30(+),  not p30(+ +), phenotype. Again,  G1x expression (with a  possible 
exception;  see below) was restricted to p30  + segregants.  The segregation pat- 
terns in the Bc-2 and Bc-3 generations are compatible with there being a single 
gene which is fully penetrant for expression of p30 antigen,  and 50% penetrant 
for G~x antigen  expression.  As with the V ÷ families,  this ratio might suggest 
another  gene  segregating  independently  of this  p30  gene  and  required  for 
expression of G~x. But again progeny testing showed no difference in expression 
of the two antigens in offspring of p30+G,x + parents as compared with p30+Gix - 
parents (Table V). 
In general,  progeny testing of mice discordant for p30 and G~x has given no 
definitive  evidence  that  these  phenotypes  are  genetically  separable.  Most 
p30+G~x  - mice gave some p30+Glx + progeny, as did one mouse ( ~ 135 in Table III) 
that was scored p30-G,x  +. The phenotype V-p30-G~x  + has not been propagable; 
among 56 progeny of 4 such segregants (Bc-1  2  135 and  d  154 in Table III and 
Bc-2 d  39 and  d  41 in Table V) only one V-p30-G~x ÷ segregant was obtained; 
obviously no conclusion can be drawn regarding this single apparent exception. 
It may be that there is a further locus inducing p30  + alone, with low penetrance, 
because among 38 total progeny from d  127 and d  128 (Table III and V), 8 were 
p30  ÷ and none Gxx  +. 
Linkage Analysis with Other Markers.  None of the three viral markers was 
associated with Gpd-l-type (chromosome 4), H-2-type  (chromosome  17) or the 
coat color loci b (chromosome 4), and In (chromosome 1). Since AK and CL mice 
do not differ at the Gpi-1 locus, which is linked to Akv-1 (36) and therefore serves 
as a marker for Akv-1  in segregation tests, we were not able to score for Gpi-1 
type to determine  which  single  V-gene segregants  were likely to be carrying 
Akv-1 in distinction to Akv-2. 
Discussion 
Interpretation  of the  Segregation  Data.  The  first  notable  feature  of this 
study of phenotypes in the backcross CL  x  (CL  x  AK) is the high  degree of 
concordance  among  the  three  markers,  V  (virus  in  tail  extracts),  p30  (viral 
protein in spleen), and G~x (expressed on the surface of thymocytes). However, 
the data indicate a more complex genetic basis than we had anticipated for the 
expression  of MuLV  antigens  in  AK  mice.  Thus  Ak  outcrosses yield  stably 
heritable  antigen-positive  genotypes  of both  (a)  virus-positive  and  b)  virus- 
negative  types.  Of the  eight  phenotypes that  could possibly be derived from 
three sets of alternative markers (V, p30, and Glx), seven were observed in the 
Bc-1 generation (Table II) but only three were certainly perpetuated on progeny 
testing,  and can thereby be ascribed to actual genotypes; these are the geno- 
types giving rise to the two parental  phenotypes V+p30+G,x + and V-p30-G~x-, 
and  the  third  genotype  yielding  the  phenotype  V-p30+G~x +  (Table  VI).  We 
propose to call the AK locus giving the V-p30  ÷ phenotype Akvp, the initials vp 
standing for "viral protein;" this designation is used because a  viral protein is 
the phenotypic basis for its recognition, and is not meant to imply that the locus 
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The segregation of  virus-positive  backcross lines  confirms earlier  studies (7, 
12) showing that AK  contains at least  two unlinked loci (Akv-1 and Akv-2) 
specifying  virus positivity,  and that appearance of  virus is regularly accompa- 
nied by expression of  p30 antigen (12).  Because the G~x  + thymocyte phenotype 
could not  be genetically  isolated  from expression of  p30 (either  alone or with V, 
Table V) there is  no evidence in our  data for  genes specifying  G~x independently 
of  genes responsible for  either complete AK virus (V  +) or p30 expression. 
From limited data, it  appears so far  that in V-p30  + segregants G~x is  demon- 
strable in thymus but not spleen, as is the case in mice of strain  129,  which 
similarly are V-p30  +. On the other hand, G~x was found also  in the spleen of 
some  V+p30  +  segregants,  as  is the  case  in  AK,  which  is the  prototype 
V+p30+G~x  + mouse (these  data are not included in this report). Thus, with 
regard to demonstrability of Gix, it may prove to be the case; (a) that the 
thymus+/spleen  + G]x  phenotype is  characteristic  of  widespread MuLV  dissemina- 
tion as in AK, whereas (b) the thyrnus+/spleen  - G~x phenotype characterizes 
"noninfectious" MuLV  expression as in 129 mice. 
In regard to the quantity of antigen expressed in the different types of 
segregant, p30 and Gxx differ.  In  V + segregants: (a)  the  level  of  p30  in  spleen  was 
generally high (+  +), (b)  p30  levels  tended to  be  positively  correlated  with MuLV 
levels,  and (c)  there was no tendency for  high or  low levels  to  be perpetuated on 
progeny testing  (Table IV).  Thus, we consider the  splenic  level  of  p30 in  V + mice 
to be phenotypic, i.e.,  secondary to the extent of  viral  replication.  On the other 
hand, all  V-p30  + mice were low in  p30 [p30(+)],  which is  consistent  with lack of 
cell-to-cell  spread of  virus in these mice. 
In contrast to p30, the degree of  G~x expression on thymocytes of  G~x  + segre- 
gants was constant, being the same in V + as compared with V- segregants and 
in  V + mice with high or  low MuLV  titers.  Apparently, the  number of  non-allelic 
G~x-inducing genes carried by each segregant did not affect  the amount of G~x 
expressed on thymocytes, since  (CL × AK)FI mice, which are heterozygous for 
all  three of  the G~x-inducing genes carried  by AK (Akv-1,  Akv-2, and  Akvp), had 
TABLE  VI 
The Three Backcross  Genotypesthatare Confirmed byProgenyTesting 
Category 
Genotype  Phenotype  Estimated 
incidence (%) 
Akv-1 and/or  Akv-2  Akvp  V  p30  G~x  in 180 Bc-1 
mice* 
1  +  +  or  -  +  +  +  136 (75.6) 
2  -  +  -  +  + 
f 
19 (10.6) 
-  +  -~ 
3  .....  25 (13.9) 
* Because progeny testing reveals that a minority of segregants of category 3 phenotype can 
generate offspring of category 1 and 2, the incidence figures (last  column) are minimal for 
categories 1 and 2, and maximal for category 3, 
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the same level  of  G1x expression (50% of  AK level)  as G~x  + segregants in the Bc-1 
and later  generations which bore only one or two of  these genes. It  is  not known 
whether homozygosity for any one of  the three loci  individually would induce 
the maximal G~x phenotype of the AKR  mouse. 
Suppression  of MuLV Phenotypes; Possible Mechanisms.  In a  number of 
instances the  phenotypes of Bc  segregants  were  not propagated on  progeny 
testing; this generally entailed the production of positive offspring by a negative 
parent. 
The question  of the  negative phenotypes which score  positive on  progeny 
testing is of considerable importance in two connections. Firstly, it has obvious 
theoretical implications, and secondly it brings to light the hazards of interpret- 
ing segregation data that depend on direct scoring alone, in the case of markers 
related to leukemia virus and its components. 
While some of the discrepancies could be due to technical errors, we suspect 
that the majority are the result of occasional suppression of the phenotypes by 
maternal transfer of antibody. Maternal transmission of resistance is a  factor 
that has long been recognized in crosses  involving leukemia incidence.  This 
phenomenon was originally recognized (37, 38) as causing a lowered incidence of 
leukemia:  (a)  in  the  hybrid  offspring of certain  crosses  as  compared  with 
progeny of reciprocal crosses, and (b) in mice foster nursed on mothers of the 
former crosses.  It was later seen to be  associated with reduced levels of the 
MuLV-associated antigen Gross leukemia cell surface antigen (GSA) in the blood 
(39), and more recently as suppression of infectious virus.  2 In the present study, 
when the Bc-1 families, which represent progeny of nine  Q Q CL mice, are con- 
sidered separately, we find evidence of maternal resistance in at least one of 
them (Table VII). 
In Table  VII the phenotypes  of the  180  Bc-1 mice are recorded in the nine family 
groups. The progeny of  one of  the CL mothers ( ~ 40) has a significantly  lower frequency of 
expression of G~x (P = 0.002)and of p30 (P < 0.001), a somewhat lower frequency of virus 
detection, and a tendency toward lower virus titers (see Fig. 1) than the rest of the Bc-1 
mice. Five of the progeny-tested  Bc-1 segregants recorded in Table III came from this 
family (c~ d  158, 159, 160, and  200  and  Q 201, selected  for  mating because  of their 
discrepant phenotypes). All except one of these (2  201) yielded Bc-2 progeny expressing 
one or more markers for which they themselves  were negative, suggesting that their 
phenotypes in respect to these markers had been suppressed. Similarly, maternal resist- 
ance may be responsible for some of the V-p30  ÷ phenotypes in the progeny of V  + Bc-2 
females (Table V,  Q  Q 281, 47, and 87). 
Secondly, it is now well established that adult mice may respond immunologi- 
cally to  certain  endogenous virus  components  (40-44);  however,  to  date  no 
naturally occurring neutralizing antibody against Gross-AK-type viruses has 
been reported. Of the three virus-related antigens scored in the present study, 
(V,  p30,  and  G~x), the  one  that  most commonly gave  a  discrepant-negative 
phenotype, revealed by progeny testing, was G~x. From the data in Table VII, 
G1x  also  appeared  to  be  the  most  subject  to  phenotypic suppression  by  the 
maternal resistance factor. This tempts us to speculate that the low penetrance 
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TABLE  VII 
Family Data for the 180 Bc-1 Segregants* 
43 
Parent no. 
CL~  (CL  ×  AK)FI~ 
No. of progeny 
51  111  11 
2  12  17 
1  10  +  13  20 
45  110  20 
3  11  33 
4  10  29 
5  13  14 
39  108  25 
40  109  11~ 
Total  180 
G~x  +  V +  p30  + 
%  %  % 
91  91  91 
76  76  88 
70  85  95 
70  85  90 
64  82  91 
59  59  76 
50  64  79 
36  72  76 
9  55  36 
* The families of  the 9 CL females have been listed  in  order of  decreasing incidence of  Gxx  + 
progeny. Most segregants were typed for H-2; there were no significant familial differ- 
ences in occurrence of  H-2 homozygotes vs. 11-2  heterozygotes. 
Of the 11 mice of  this "lowest score" family, 4 c~  c~ were progeny tested, and all yielded 
segregants that were positive for one or more of  the three markers for which the tested 
male parents were negative (the one progeny-tested female did not),  see text. 
of G~x in this study may represent  antigenic modulation, a phenomenon well 
recognized for another thymocyte membrane antigen, thymus-leukemia (45, 46). 
The MuLV-associated antigen GSA is also said to be susceptible to antigenic 
modulation (47). 
Summary 
In a  further genetic study of murine leukemia virus (MuLV) and its compo- 
nents we examined the backcross C57L  x  (C57L  x  AKR). This population was 
selected  because  strains  AKR  and  C57L  are  both Fv-1 n,  and  the  restriction 
which the Fv-lb allele imposes on the output of virus was thereby obviated. The 
segregants  were  scored  for  three  characters:  (a)  infectious  Gross-AKR-type 
MuLV (V), in the tail; (b) group-specific antigen indicative of p30 internal viral 
protein,  in spleen; and (c) G~x antigen,  now thought to be indicative of gp69/71 
viral envelope glycoprotein, on thymocytes. Our conclusions are:  (a) It is con- 
firmed that the AKR mouse has two unlinked  chromosomal genes, Akv-1  and 
Akv-2,  each of which can independently give rise to the life-long high output of 
MuLV that is characteristic of AKR mice. (b) Of the eight phenotypes that could 
possibly be derived from segregation of the three pairs of independent alterna- 
tive traits,  seven were observed, but on progeny testing only three were shown 
to reflect stably heritable  genotypes; these were V+p30+G~x  + and  V-p30-G~x- 
(the  parental  types)  and  V-p30+Gix  +.  A  third,  newly  identified  AKR  gene, 
designated Akvp,  segregating  independently of Akv-1 and Akv-2,  also  deter- 
mines expression of p30 and G1x but in this case independently of XC-detectable 
MuLV. (c) The four remaining observed phenotypes, which did not breed true on 44  MURINE  LEUKEMIA  VIRUS  ANTIGENS  IN  AKR  CROSSES 
progeny  testing,  involved  mostly  antigen-negative  parents  yielding  antigen° 
positive progeny; it is likely that these discrepancies represented suppression of 
phenotype by a  maternal resistance factor. 
We wish to thank Dr. Y. Obata and Mrs. P. Patel for their technical  assistance. 
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